Phase II trial of concomitant low dose temozolomide with external beam radiation (EBRT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Preliminary results of RTOG 04-20.
Conference
Lieberman, FS, Tsien, C, Berkey, B et al. (2006). Phase II trial of concomitant low dose temozolomide with external beam radiation (EBRT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Preliminary results of RTOG 04-20.
. JOURNAL OF CLINICAL ONCOLOGY, 24(18), 60S-60S.
Lieberman, FS, Tsien, C, Berkey, B et al. (2006). Phase II trial of concomitant low dose temozolomide with external beam radiation (EBRT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Preliminary results of RTOG 04-20.
. JOURNAL OF CLINICAL ONCOLOGY, 24(18), 60S-60S.